Loo LS, Tang JP, Kohl S.: Inhibition of cellular cytotoxicity for herpes simplex vitus-infected cells in vitro and in vivo by intralipid. J Infect Dis146:64, 1982
4.
Fischer GW, Wilson SR, Hunter KW, et al: Diminished bacterial defenses with intralipid. Lancet2:819, 1980
5.
Ota DM, Jessup JM, Bacock GF, et al: Immune function during intravenous administration of a soybean oil emulsion. JPEN9:23, 1985
6.
Freedman Z., Marks KH, Maisels J.: Effect of parenteral fat emulsions on pulmonary reticuloendothelial systems in the new born infant. Pediatrics61:694, 1978
7.
Moncada S., Vane J.: Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Eng J Med17:1142. 1979
8.
Moncada S. Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides. thromboxane A2 and prostaglandin. Pharmacol Rev30:293. 1979
9.
Hechtman HBHuval WVMathieson MA et al: Prostaglandin and thromboxane mediation of cardiopulmonary failure . Surg Clin North Am63:263, 1983
10.
Rietschel ETSchade U., Luederitz H., et al: Prostaglandins in endotoxicosis. IN Microbiology , Shlessinger D (ed). Am Soc for Microbiol. Washington, DC. 1980 : pp. 66-72
11.
Goodwin JS, Webb DR: Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol15:106, 1980
12.
Goodwin J., Ceuppens J.: Special article: Regulation of the immune response by prostaglandins . J Clin Immunol3:295, 1983
13.
Stobb JD, Kennedy MS, Goldyne ME: Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T cell subpopulation. J Clin Invest64:1188, 1979
14.
Herman J., Rabsion AR: Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin 1 production by large granular lymphocytes. Clin Exp Immunol57:380, 1984
15.
Kunkel SL, Chensue SW, Phan SH: Prostaglandins as endogenous mediators of interleukin 1 production . J Immunol136:186, 1986
16.
Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate . J Immunol137:3189, 1986
17.
Mertin J., Hughes D.: Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and RPD. Int Arch Allergy Appl Immunol48:203, 1975
18.
Carroll RK, Khor HT: Dietary fat in relation to tumorigenesis IN Progressive Biochemistry Pharmacology. vol. XB. Kager (ed). Plenum, New York, 1975, p308
19.
Selivonchick DP, Johnston PV: Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J Nutri105:288, 1975
20.
Bloj B., Morero RD, Faeias RN, et al: Membrane lipid fatty acids and regulation of membrane-bound enzymes. Biochim Biophys Acta311:67, 1973
21.
McMurchie E. , Raison JK: Membrane lipid fluidty and its effect on the activation energy of membrane-associated enzymes. Biochim Biophys Acta554:364, 1979
22.
Colard O., Kervabon A., Roy C.: Effects on adenylate cyclase activities of unsaturated fatty acid incorporation into rat liver plasma membrane phospholipids. Specific modulation by linoleate . Biochim Biophys Acta95:97, 1980
23.
Bretin M., Wolf C., Colsrd Q.: Linoleate incorporation into rat liver membranes phospholipids: Effect on plasma membrane ATPase activities and physical properties. Biochem Biophys Res Commun117:809, 1983
24.
Ribinson HJ , Granda JL: Prostaglandins in synovial inflammatory disease . Surg Forum25:476, 1974
25.
Blasinngham MC, Selkurt EE: Role of the lung in metabolism of prostaglandin E during severe hemorrhagic shock in the dog. Circ Shock15:175, 1985
26.
Fletcher JR, RW Ramwell: The role of prostaglandin synthetase inhibitors in shock and trauma . IN Prostaglandin Synthetase Inhibitors: New Cinical Application , Ramwell P, (ed). Alan R Liss, Inc., New York, 1980 ; p257
27.
Prescott SMThe effect of eicosapentaenoic acid on leukotriene B production by human neutrophils. J Biol Chem259:7615, 1984
28.
Mohamed Shakir KM, O'Brian JTGartner SL: Enhanched phospholipase A2 activity in rat plasma, liver and intestinal muscosa following endotoxin treatment: A possible explantation for the protective effect of indomethacin in endotoxic shock . Metabolism34:176, 1985
29.
Evers AS, Murphree., Saffitz JE, et al: Effects of endogenously produced leukotrienes thromboxanes and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest75:992, 1985
30.
Baracos V., Rodemann HPDinarello CA et al: Stimulation of muscle protein degradation and prostaglandin E_ release by leukocytic pyrogen (interleukin-I)N Eng J Med308:553, 1983
31.
Samuelsson B.Leukrotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science220:568, 1983
32.
Hansson G.Bjorck T.Dahlen SE, et al: Specific allergen induces contraction of bronchi and formation of leukotrienes C4, D4 and E4 in human asthmatic lungs. Adv Prostaglandin Thromboxane Leukotriene Res12:153, 1983
33.
Wolbling RHAchringhaus U., Peskar BM, et al: Release of slow reacting substance of anaphylaxis from layers of guinea pig aorta. Prostaglandins25:823, 1983
34.
Mullane K., Barst S.Mcgiff JCLeukotrienes in myocardial ischemia. IN Leukotrienes in Cardiovascular and Pulmonary Function, Lefer AM, Gee MH, (eds). Alan R. Liss, Inc. , New York, 1985 , p 727
35.
Sirois P., Borgeat P., Jeanson A.The action of leukotriene B4 on the lung. Prostaglandins Med5:429, 1980
36.
Pacitli N., Bryson SE, Rodger IW, et al. Leukotriene antagonist FPL 57231 prevents the acute pulmonary effects of Eschicheria coli endotoxin in cats. Circ Shock21:155, 1987
37.
Palmblad J. , Malmsten CL, et al: Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood58:658, 1981
38.
Baracos VE, Wilson EJ, Goldberg ALEffects of the temperature on protein turnover in isolated rat skeletal muscle . Am J Physiol246:125, 1984
39.
Marshall LA , Johsonston PVThe influence of dietary essential fatty acids on rat immunocompetent cell, prostaglandin synthesis and mitogen-induced blastogenesis . J Nutr115:1572, 1985
40.
Webb DR, Weider KJ, Nowowiejski I.: Prostaglandins in lymphocyte suppressor mechanisms. Adv Immunopharmacol2:383, 1980
41.
Bankhurst ADThe modulation of human killer cells activity by prostaglandins. J Clin Lab Immunol7:85, 1982
42.
Henny CS, Bourne HR, Lichtenstein LMThe role of cyclic 3'5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol108:1526, 1972
43.
Jordan ML, Hoffman RA, et al: Prostaglandin E2 mediates subset specific effects on the functional responses of allosensitized T-lymphocyte clones. Transplantation43:117, 1987
44.
Mertin JC, Stackpoole A., Shumway SJ: Prostaglandins and cell-mediated immunity. The role of prostaglandin E1 in the induction of host-versus-graft and graft-versus-host reactions in mice . Transplantation37:396, 1984
45.
Faist E., Mewes A., Baker C., et al. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha-2 production in patients with major trauma. J Trauma27:837, 1987
46.
Sheu CW, Freese E.: Lipopolysaccharide layer protection of gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol115:869, 1973
47.
Kodicek E., Worden ANEffect of unsaturated fatty acids on Lactobacillus helveticus and other gram-positive microorganisms. Biochem39:78, 1945
48.
Galbraith H. , Miller TB: Effect of metal cations and pH on the antibacterial activity and uptake of long chain fatty acids. J Appl Bacteriol36:635, 1973
49.
Kodicek E.: The effect of unsaturated fatty acids on gram-positive bacteria. Soc Exp Biol Symp3:217, 1949
50.
Saba TM, Luzio NR: Reticloendothelial blockage and recovery as a function of opsonic activity . Am J Physiol216:197, 1969
51.
Lauser ME, Saba TM: Neutrophil-mediated lung location of bacteria : A mechanism for pulmonary injury. Surgery90:473, 1982
Sobrado J., Moldawer L., Pomposelli J., et al: Lipid emulsions and reticuloendothelial system function in healthy and burned guinea pigs. Am J Clin Nutr42:855, 1985
54.
Babayan VK: Medium chain triglycerides and structured lipids. Lipids22:417, 1987
55.
Bach AC, Babayan VK: Medium chain triglycerides; An update. Am J Clin Nutr36:950, 1982
56.
Sailer D., Muller M.: Medium chain triglycerides in parenteral nutrition. JPEN5:115, 1981
57.
Guisard D., Debry G.: Metabolic effects of a medium chain triglyceride emulsion emulsion injected intravenously in man. Horm Metab Res4:509, 1972
58.
Maiz A., Yamazaki K., Sobrado J., et al: Hypocaloric lipid emulsions and amino acid metabolism in injured rats. JPEN8:361, 1984
59.
Mok KT, Maiz A., Sobrado J., Yamazaki K., et al: Structured medium chain and long chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat . Metabolism10:910, 1984
60.
Gordon EE, Duger J.: Experimental hyperosmolar diabetic syndrome. Ketogenic response to medium-chain triglycerides. Diabetes24:301, 1975
61.
Bach A., Guisard D., Debry G., Metais P.: Metabolic effects following a medium chain triglycerides load in dogs . Influence of the perfusion rate. Arch Int Physiol Biochim82:705, 1974
62.
DeMichele S. , Karlstad MP, et al: Enhanced muscle and liver protein synthesis with the modified dietary fat in enterally fed burned rats . Circ Shock21:340, 1987
63.
Croft KD, Beilin LJ, Vandongen R., et al: Dietary modification of fatty acid and prostaglandin synthesis in the rat. Biochim Biophys Acta795:196, 1984
64.
Wan J., Grimble RF: Effect of dietary linoleate content on the metabolic response of rats to Escherichia coli endotoxin. Clin Sci72:383, 1987
65.
Magrum LJ, Johnston PV: Modulation of prostaglandin synthesis in rat peritoneal macrophages with W-3 fatty acids. Lipids18:514, 1983
66.
Magrum LJ, Johnson PV: Effect of culture in vitro with eicosatetraenoic (20:4w6) and eicosapentaenoic (20:5w3) acids on fatty acid composition, prostaglandin synthesis and chemiluminescence of rat peritoneal macrophages. Biochim Biophys Acta836:354, 1984
Strasser T. , Fischer S., Weber PC: Leukotriene B5 is formed in human with eicosapentaenoic acid. Proc Natl Acad Sci USA82:1540, 1985
69.
Sanders TAB , Younger K.: The effect of dietary supplements of w-3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasmas choline phosphoglycerides. Br J Nutr45:613, 1981
70.
Lee TH, Hoover RL, Williams JD, et al: Effect of dietary enrichment with eicosapentaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function . N Eng J Med312:1217, 1985
71.
Goldman DW, Pickett WC, Goetzl EJ: Human neutrophil chemotactic and degranulating activities of leukotriene B5 derived from eicosapentaenoic acid. Biochem Biophys Res Commun117:282, 1983
72.
Alexander JW , Saito H., Ogle CK, et al: The importance of lipid type in the diet after burn injury. Ann Surg204:1, 1983
73.
Trocki O., Heyd TJ, Weymack JP, et al: Effects of fish oil on postburn metabolism and immunity. JPEN2:521, 1987
74.
Pomposelli JJ, Flores EA, Bistrian BR, et al: Long-term fish oil enriched diets attenuate the metabolic effects of endotoxin in guinea pigs. JPEN12(Supp):40, 1988
75.
Kirkman RL, Barrett LV, et al: A fish oil vehicle increases the therapeutic index of cyclosporine . Surg Forum38:394, 1987
76.
Teo TC, DeMichele, Selleck K., et al: Administration of structured lipid (SL) composed of MCT and dFish oil reduces catablism in enterally fed burned rats (abstr). Fed Am Soc Exp Biol2:A641, 1988
